Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
ViLim Ball technology helps reduce uncontrollable shaking hands

ViLim Ball technology helps reduce uncontrollable shaking hands

The London Clinic exhibits innovative technology to treat Parkinson’s disease at Arab Health

The London Clinic exhibits innovative technology to treat Parkinson’s disease at Arab Health

Study reveals how devastating mitochondrial diseases strike families without any previous history

Study reveals how devastating mitochondrial diseases strike families without any previous history

Mitochondrial impairment may actually protect the brain in Parkinson's disease, study shows

Mitochondrial impairment may actually protect the brain in Parkinson's disease, study shows

Administration of two proteins shown to counteract neurodegeneration in Parkinson's disease

Administration of two proteins shown to counteract neurodegeneration in Parkinson's disease

Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s disease

Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s disease

Study finds overall pattern of commonality between Huntington's and Parkinson's

Study finds overall pattern of commonality between Huntington's and Parkinson's

Mount Sinai study uncovers potential link between Crohn's and Parkinson's in Jewish population

Mount Sinai study uncovers potential link between Crohn's and Parkinson's in Jewish population

Insilico Medicine develops new deep-learning based hematological human aging clock

Insilico Medicine develops new deep-learning based hematological human aging clock

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Genetic differences can influence efficiency of medicines

Genetic differences can influence efficiency of medicines

Study finds new brainstem changes in Parkinson’s disease

Study finds new brainstem changes in Parkinson’s disease

Testing blood for caffeine levels may aid diagnosis of Parkinson's disease

Testing blood for caffeine levels may aid diagnosis of Parkinson's disease

Discovery of key protein’s structure may help improve drug design

Discovery of key protein’s structure may help improve drug design

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

New AAN guideline: Exercising twice a week may improve memory in people with MCI

New AAN guideline: Exercising twice a week may improve memory in people with MCI

Researchers sequence salamander genome to reveal unique features of regeneration

Researchers sequence salamander genome to reveal unique features of regeneration

Scientists elucidate why exercise slows progression of Parkinson's disease

Scientists elucidate why exercise slows progression of Parkinson's disease

Brain activity patterns linked to clinical outcomes achieved through DBS in dystonia patients

Brain activity patterns linked to clinical outcomes achieved through DBS in dystonia patients

Deep brain stimulation may improve survival for Parkinson's patients

Deep brain stimulation may improve survival for Parkinson's patients